Effect of Breathıng Exercıse Applıed to Indıvıduals Wıth Copd on Respıratory Functıon, Dyspnea and Qualıty of Lıfe

November 22, 2024 updated by: Aybike Kose, Ondokuz Mayıs University

Purpose of the research This research was designed to determine the effect of breathing exercise applied to individuals diagnosed with COPD on respiratory function, dyspnea and quality of life.

Hypotheses of the Research H0a: Breathing exercise applied to individuals diagnosed with COPD has no effect on the respiratory function test FEV1/FVC.

H1a: Breathing exercise applied to individuals diagnosed with COPD has an effect on the respiratory function test FEV1/FVC.

H0b: Breathing exercise applied to individuals diagnosed with COPD has no effect on dyspnea.

H1b: Breathing exercise applied to individuals diagnosed with COPD has an effect on dyspnea.

H0c: Breathing exercise applied to individuals diagnosed with COPD has no effect on quality of life.

H1c: Breathing exercise applied to individuals diagnosed with COPD has an effect on the quality of life.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Samsun, Turkey, 55
        • Ondokuz Mayis University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed with COPD for at least 1 year, confirmed by pulmonary function test
  • Those who voluntarily accepted to participate in the research
  • Those aged 18 and over,
  • Individuals who have access to the hospital

Exclusion Criteria:

  • In COPD exacerbation period,
  • Having a neurological or psychiatric diagnosis,
  • Those with obesity,
  • Those with physical disabilities (vision, hearing, walking, etc.),
  • Those who are pregnant,
  • Illiterate
  • Diagnosed with another disease that significantly affects the respiratory system (scoliosis, lung cancer, abdominal tumor, etc.).
  • Patients who have previously participated in an exercise program will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
Control group patients will not undergo any exercise and the normal clinical protocol will not be interfered with.
Experimental: breathing exercise group
The researcher will make the application group patients perform a 30-minute pranayama exercise twice a week for 6 weeks.
Other: pranayama breathing exercise
Normal breathing, focusing on breathing, Alternative Nose Breathing, Cooling Breath, Bee Buzzing Sound, A breathing exercise of 20 minutes in total, consisting of 5 stages: normal breathing and focusing on breathing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pulmonary function test
Time Frame: 6 weeks
The effect of breathing exercise applied to individuals with COPD on respiratory function test FEV1/FVC
6 weeks
Dyspnea severity
Time Frame: 6 weeks
The effect of breathing exercise applied to individuals with COPD on dyspnea
6 weeks
Saint George's Solunum Anket
Time Frame: 6 weeks
The effect of breathing exercise applied to individuals with COPD on quality of life
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ondokuz Mayıs University

Investigators

  • Study Chair: Aybike KÖSE, 1, Ondokuz Mayıs University
  • Study Director: Afitap ÖZDELİKARA, 2, Ondokuz Mayıs University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Actual)

July 1, 2024

Study Completion (Actual)

July 25, 2024

Study Registration Dates

First Submitted

November 21, 2024

First Submitted That Met QC Criteria

November 22, 2024

First Posted (Estimated)

November 26, 2024

Study Record Updates

Last Update Posted (Estimated)

November 26, 2024

Last Update Submitted That Met QC Criteria

November 22, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OMU-SBF-HEM-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on pranayama breathing exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe